Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Studies on Osteocytes in Their 3D Native Matrix Versus 2D In Vitro Models.

Zhang C, Bakker AD, Klein-Nulend J, Bravenboer N.

Curr Osteoporos Rep. 2019 Aug;17(4):207-216. doi: 10.1007/s11914-019-00521-1. Review.

PMID:
31240566
2.

Relative importance of four functional measures as predictors of 15-year mortality in the older Dutch population.

Eekhoff EMW, van Schoor NM, Biedermann JS, Oosterwerff MM, de Jongh R, Bravenboer N, van Poppel MNM, Deeg DJH.

BMC Geriatr. 2019 Mar 25;19(1):92. doi: 10.1186/s12877-019-1092-4.

3.

Evolution of heterotopic bone in fibrodysplasia ossificans progressiva: An [18F]NaF PET/CT study.

Botman E, Raijmakers PGHM, Yaqub M, Teunissen B, Netelenbos C, Lubbers W, Schwarte LA, Micha D, Bravenboer N, Schoenmaker T, de Vries TJ, Pals G, Smit JM, Koolwijk P, Trotter DG, Lammertsma AA, Eekhoff EMW.

Bone. 2019 Jul;124:1-6. doi: 10.1016/j.bone.2019.03.009. Epub 2019 Mar 8.

PMID:
30858149
4.

In Vivo Models of Mechanical Loading.

Javaheri B, Bravenboer N, Bakker AD, van der Veen A, de Souza RL, Saxon L, Pitsillides AA.

Methods Mol Biol. 2019;1914:369-390. doi: 10.1007/978-1-4939-8997-3_22.

PMID:
30729478
5.

Effects of different training modalities on phosphate homeostasis and local vitamin D metabolism in rat bone.

Buskermolen J, van der Meijden K, Furrer R, Mons DJ, van Essen HW, Heijboer AC, Lips P, Jaspers RT, Bravenboer N.

PeerJ. 2019 Jan 24;7:e6184. doi: 10.7717/peerj.6184. eCollection 2019.

6.

The effect of PPARγ inhibition on bone marrow adipose tissue and bone in C3H/HeJ mice.

Beekman KM, Veldhuis-Vlug AG, van der Veen A, den Heijer M, Maas M, Kerckhofs G, Parac-Vogt TN, Bisschop PH, Bravenboer N.

Am J Physiol Endocrinol Metab. 2019 Jan 1;316(1):E96-E105. doi: 10.1152/ajpendo.00265.2018. Epub 2018 Nov 20.

PMID:
30457914
7.

The effect of Activin-A on periodontal ligament fibroblasts-mediated osteoclast formation in healthy donors and in patients with fibrodysplasia ossificans progressiva.

Schoenmaker T, Wouters F, Micha D, Forouzanfar T, Netelenbos C, Eekhoff EMW, Bravenboer N, de Vries TJ.

J Cell Physiol. 2019 Jul;234(7):10238-10247. doi: 10.1002/jcp.27693. Epub 2018 Nov 11.

8.

Resorption of the mandibular residual ridge: A micro-CT and histomorphometrical analysis.

Dekker H, Schulten EAJM, Ten Bruggenkate CM, Bloemena E, van Ruijven L, Bravenboer N.

Gerodontology. 2018 May 21. doi: 10.1111/ger.12343. [Epub ahead of print]

PMID:
29781536
9.

Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography.

Bruijnen STG, Verweij NJF, van Duivenvoorde LM, Bravenboer N, Baeten DLP, van Denderen CJ, van der Horst-Bruinsma IE, Voskuyl AE, Custers M, van de Ven PM, Bot JCJ, Boden BJH, Lammertsma AA, Hoekstra OSH, Raijmakers PGHM, van der Laken CJ.

Rheumatology (Oxford). 2018 Apr 1;57(4):770. doi: 10.1093/rheumatology/key034. No abstract available.

10.

Blood Vessel Formation and Bone Regeneration Potential of the Stromal Vascular Fraction Seeded on a Calcium Phosphate Scaffold in the Human Maxillary Sinus Floor Elevation Model.

Farré-Guasch E, Bravenboer N, Helder MN, Schulten EAJM, Ten Bruggenkate CM, Klein-Nulend J.

Materials (Basel). 2018 Jan 20;11(1). pii: E161. doi: 10.3390/ma11010161.

11.

Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography.

Bruijnen STG, Verweij NJF, van Duivenvoorde LM, Bravenboer N, Baeten DLP, van Denderen CJ, van der Horst-Bruinsma IE, Voskuyl AE, Custers M, van de Ven PM, Bot JCJ, Boden BJH, Lammertsma AA, Hoekstra OSH, Raijmakers PGHM, van der Laken CJ.

Rheumatology (Oxford). 2018 Apr 1;57(4):631-638. doi: 10.1093/rheumatology/kex448. Erratum in: Rheumatology (Oxford). 2018 Apr 1;57(4):770.

12.

The effect of raloxifene on bone marrow adipose tissue and bone turnover in postmenopausal women with osteoporosis.

Beekman KM, Veldhuis-Vlug AG, den Heijer M, Maas M, Oleksik AM, Tanck MW, Ott SM, van 't Hof RJ, Lips P, Bisschop PH, Bravenboer N.

Bone. 2019 Jan;118:62-68. doi: 10.1016/j.bone.2017.10.011. Epub 2017 Oct 11.

PMID:
29032175
13.

[18F]NaF PET/CT scan as an early marker of heterotopic ossification in fibrodysplasia ossificans progressiva.

Eekhoff EMW, Botman E, Coen Netelenbos J, de Graaf P, Bravenboer N, Micha D, Pals G, de Vries TJ, Schoenmaker T, Hoebink M, Lammertsma AA, Raijmakers PGHM.

Bone. 2018 Apr;109:143-146. doi: 10.1016/j.bone.2017.08.012. Epub 2017 Aug 18.

PMID:
28826841
14.

Periodontal ligament fibroblasts as a cell model to study osteogenesis and osteoclastogenesis in fibrodysplasia ossificans progressiva.

de Vries TJ, Schoenmaker T, Micha D, Hogervorst J, Bouskla S, Forouzanfar T, Pals G, Netelenbos C, Eekhoff EMW, Bravenboer N.

Bone. 2018 Apr;109:168-177. doi: 10.1016/j.bone.2017.07.007. Epub 2017 Jul 10.

PMID:
28705683
15.

Flare-Up After Maxillofacial Surgery in a Patient With Fibrodysplasia Ossificans Progressiva: An [18F]-NaF PET/CT Study and a Systematic Review.

Eekhoff EMW, Netelenbos JC, de Graaf P, Hoebink M, Bravenboer N, Micha D, Pals G, de Vries TJ, Lammertsma AA, Raijmakers PG, van Es RJ.

JBMR Plus. 2017 Jul 5;2(1):55-58. doi: 10.1002/jbm4.10008. eCollection 2018 Jan.

16.

Cytokines TNF-α, IL-6, IL-17F, and IL-4 Differentially Affect Osteogenic Differentiation of Human Adipose Stem Cells.

Bastidas-Coral AP, Bakker AD, Zandieh-Doulabi B, Kleverlaan CJ, Bravenboer N, Forouzanfar T, Klein-Nulend J.

Stem Cells Int. 2016;2016:1318256. doi: 10.1155/2016/1318256. Epub 2016 Sep 7.

17.

Osteocyte isolation and culture methods.

Shah KM, Stern MM, Stern AR, Pathak JL, Bravenboer N, Bakker AD.

Bonekey Rep. 2016 Sep 14;5:838. doi: 10.1038/bonekey.2016.65. eCollection 2016.

18.

Serum of patients with active rheumatoid arthritis inhibits differentiation of osteochondrogenic precursor cells.

Pathak JL, Verschueren P, Lems WF, Bravenboer N, Klein-Nulend J, Bakker AD, Luyten FP.

Connect Tissue Res. 2016 May;57(3):226-35. doi: 10.3109/03008207.2016.1146714. Epub 2016 Apr 6.

PMID:
27050327
19.

Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression.

Pathak JL, Bakker AD, Luyten FP, Verschueren P, Lems WF, Klein-Nulend J, Bravenboer N.

Calcif Tissue Int. 2016 Jun;98(6):596-608. doi: 10.1007/s00223-016-0116-8. Epub 2016 Feb 18.

PMID:
26887974
20.

Inhibition of TGFβ signaling decreases osteogenic differentiation of fibrodysplasia ossificans progressiva fibroblasts in a novel in vitro model of the disease.

Micha D, Voermans E, Eekhoff MEW, van Essen HW, Zandieh-Doulabi B, Netelenbos C, Rustemeyer T, Sistermans EA, Pals G, Bravenboer N.

Bone. 2016 Mar;84:169-180. doi: 10.1016/j.bone.2016.01.004. Epub 2016 Jan 6.

PMID:
26769004

Supplemental Content

Loading ...
Support Center